Dr. Bhoj's research expertise lies in the area of cellular immunotherapy. In particular, he has experience in preclinical development of immunotherapy that employ engineered immuno-receptors (e.g. chimeric antigen receptors) for the treatment of cancer and of non-malignant conditions such as autoimmunity and transplant rejection.
In addition to conducting preclinical in vitro and in vivo studies using animal models, Dr. Bhoj has experience in conducting correlative studies in patients undergoing immunotherapy to study the immune impact of such therapies.